In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 | Sep-30-18 | Sep-30-17 | Sep-30-16 | Sep-30-15 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Interest income: |
Interest income on loans | 56.1 | 54.5 | 55.7 | 56.5 | 53.4 | 48.2 | 49.1 | 45.1 |
Interest income on investments | 5.7 | 3.8 | 7.3 | 9.7 | 9.7 | 9.2 | 8.5 | 8.2 |
| 62.8 | 58.7 | 64.1 | 67.8 | 64.5 | 58.3 | 58.4 | 54.2 |
Interest expense: |
Interest on deposits | 2.7 | 5.5 | 10.5 | 14.4 | 10.3 | 8.5 | 7.6 | 7.4 |
| 3.0 | 5.8 | 15.9 | 20.7 | 16.3 | 12.8 | 11.4 | 10.4 |
Net interest income | 59.8 | 52.9 | 48.2 | 47.0 | 48.2 | 45.5 | 46.9 | 43.8 |
Provision for loan losses | | 2.7 | 3.3 | 2.1 | 4.0 | 3.4 | 2.6 | 2.1 |
Net interest income after provision for loan losses | 59.8 | 50.2 | 44.9 | 44.9 | 44.2 | 42.2 | 44.4 | 41.7 |
Deposit and loan fees | | | | | | | 3.6 | 3.3 |
Gain on sale of investments, net | | | | | | | 1.3 | 0.8 |
Other non-interest income | 8.5 | 11.5 | 13.3 | 8.2 | 7.8 | 8.2 | 4.0 | 3.8 |
Total non-interest income | 8.5 | 11.5 | 13.3 | 8.2 | 7.8 | 8.2 | 8.8 | 7.9 |
Non-interest expenses | 43.3 | 41.8 | 40.6 | 38.1 | 39.9 | 41.4 | 42.9 | 36.9 |
Pre-tax income before non-recurring items | 25.0 | 19.9 | 17.6 | 15.0 | 12.2 | 8.9 | 10.6 | 13.0 |
Non-recurring items | | | | | | | 0.2 | 0.3 |
Pre-tax income | 25.0 | 19.9 | 17.6 | 15.0 | 12.2 | 8.9 | 10.3 | 12.7 |
Income taxes | 4.9 | 3.5 | 3.2 | 2.4 | 5.7 | 1.6 | 2.6 | 3.0 |
Tax rate | 19.7% | 17.5% | 18.1% | 16.1% | 46.4% | 17.8% | 25.1% | 23.2% |
Net income | 20.1 | 16.4 | 14.4 | 12.6 | 6.5 | 7.3 | 7.7 | 9.8 |
Net margin | 29.1% | 26.6% | 24.8% | 23.8% | 12.5% | 14.6% | 14.5% | 19.7% |
|
Basic EPS | $2.06 | $1.65 | $1.39 | $1.18 | $0.60 | $0.69 | $0.74 | $0.94 |
Diluted EPS | $2.06 | $1.65 | $1.39 | $1.18 | $0.60 | $0.69 | $0.73 | $0.93 |
|
Shares outstanding (basic) | 9.8 | 9.9 | 10.3 | 10.7 | 10.8 | 10.6 | 10.4 | 10.5 |
Shares outstanding (diluted) | 9.8 | 9.9 | 10.3 | 10.7 | 10.8 | 10.7 | 10.5 | 10.5 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |